epigallocatechin gallate has been researched along with Squamous Cell Carcinoma of Head and Neck in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, HJ; Kwon, HW; Lee, SH; Lim, YC; Nam, HJ | 1 |
| Chen, WT; Chen, YJ; Chung, LC; Feng, TH; Juang, HH; Lee, JC | 1 |
| Katiyar, SK | 1 |
| Chen, SC; Funayama, S; Ho, CT; Hou, SC; Kao, MC; Lin, HY; Way, TD; Yu, CC | 1 |
| Baek, SJ; Kang, SU; Kim, CH; Lee, BS; Lee, SH; Shin, YS | 1 |
| Cai, GM; Hunag, DH; Liu, Y; Pi, LM; Qiu, YZ; Tian, YQ; Yu, CY; Zhang, X | 1 |
1 review(s) available for epigallocatechin gallate and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Head and Neck Neoplasms; Humans; Lignans; Magnolia; Polyphenols; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Tea; Vitis | 2016 |
5 other study(ies) available for epigallocatechin gallate and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Protein 2; Neoplastic Stem Cells; Receptors, Notch; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transfection; Xenograft Model Antitumor Assays | 2013 |
Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Topics: Animals; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; G1 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Head and Neck Neoplasms; Humans; Immediate-Early Proteins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
(-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Catechin; Down-Regulation; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2012 |
Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.
Topics: Anticarcinogenic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Growth Differentiation Factor 15; Head and Neck Neoplasms; Heterografts; Humans; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53 | 2013 |
[EGCG regulates TGF-β1-induced epithelial mesenchymal transition in squamous cell carcinoma of head and neck].
Topics: Antigens, CD; Cadherins; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Signal Transduction; Smad7 Protein; Squamous Cell Carcinoma of Head and Neck; Transforming Growth Factor beta1; Vimentin | 2012 |